biome glp 1 Bio.me GLP-1 Support – Multi-Benefit GLP-1 Powder for Weight Management & Digestive Health – Sustain Energy Levels GLP Superfood™ – LevelUp

Limited Long-Term Data Mounjaro only approved in 2022 Zepbound only approved in 2023 Long-term safety profile still emerging Unknown effects of decades-long use 2

primarily focus on other alleged side effects, such as gastrointestinal injuries, including gastroparesis and intestinal obstruction

JNK activation is associated with intracellular beta-amyloid accumulation

If hot flashes occur during tirzepatide treatment, several practical strategies may provide relief while continuing therapy

Between 1969 and 1971, work by John Brown and Raymond Pederson, together with the peptide chemistry expertise of Erik Jorpes and Viktor Mutt [67], led to the identification of the gastric inhibitory polypeptide (GIP), a 42-amino acid polypeptide that was named based on its potency to suppress gastric motility and gastric acid secretion [[68], [69], [70]]